Keyword Analysis & Research: replication competent virus defined

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
replication competent virus defined	0.53	0.1	1128	56	35
replication	1.15	0.7	5548	46	11
competent	0.32	0.5	8949	86	9
virus	1.38	0.1	2955	87	5
defined	1.3	0.5	5001	13	7

Keyword	CPC	PCC	Volume	Score
replication competent virus defined	1.41	0.1	1187	91
replication competent virus definition	1.57	0.8	3614	81
replication-competent	0.11	0.5	4876	24
replication of a virus	0.05	0.4	9219	94
replication-competent adenovirus	0.01	0.2	332	19
replication of virus pdf	0.41	0.9	5783	51
replication-incompetent	0.72	0.3	2314	5
review on virus replication and infection	1.61	1	6598	63
replication of viruses microbiology	1.76	1	5600	85
replication defective virus definition	1.41	1	3395	12
what is viral replication	0.76	0.8	9107	32
examples of a virus replication	1.26	0.5	4119	27
replication of animal viruses	0.93	0.2	5933	20
process of virus replication	1	0.7	5705	19
the viruses and their replication	0.25	0.6	5910	64
review on virus replication cycle	0.87	0.4	6560	2
virus replication in host cell	0.06	0.7	2137	89
replication cycle of virus	0.39	0.3	6843	30
processes of replication for viruses	1.43	0.5	8648	67
viral replication definition biology	1.17	0.4	2085	98
how to virus replicate	0.35	0.4	1313	81
what does a virus require to replicate	0.52	0.2	9468	36

Review Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing
sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S2329050122001681

WEBMar 9, 2023 · Replacing the gammaretroviral genome with a transgene of interest generates a replication-defective virus (vector) that is capable of high-efficiency gene transfer ( Figure 1 A ). The vector must be packaged into a virion, which is accomplished by independently expressing the viral genes ( Figure 1 B).

DA: 34 PA: 11 MOZ Rank: 88

Meeting FDA Guidance recommendations for replication-competent virus
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791246/

WEBMar 3, 2023 · Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing - PMC. Journal List. Mol Ther Methods Clin Dev. v.28; 2023 Mar 9. PMC9791246. As a library, NLM provides access to scientific literature. DOI: 10.1016/j.omtm.2022.11.009 Published: 2023/03/03

DOI: 10.1016/j.omtm.2022.11.009
Published: 2023/03/03

DA: 27 PA: 64 MOZ Rank: 11

Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968310/

WEBAug 1, 2015 · Replication-competent (oncolytic) viruses (OV) are not similarly limited to certain indications, as they can, via oncolysis, release the unique tumor epitopes from each patient's own tumor and can, therefore, be considered as in situ vaccines. Author: Dmitriy Zamarin, Sari Pesonen Publish Year: 2015 DOI: 10.1089/hum.2015.055 Publication: Hum Gene Ther. 2015 Aug 1; 26(8): 538-549.

Author: Dmitriy Zamarin, Sari Pesonen
Publish Year: 2015
DOI: 10.1089/hum.2015.055
Publication: Hum Gene Ther. 2015 Aug 1; 26(8): 538-549.

DA: 11 PA: 35 MOZ Rank: 82

A Comparative Study of Replication-Incompetent and -Competent
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443908/

WEBJun 6, 2017 · Here, we analyzed the adaptive immune system’s response following viral infection by comparing replication-incompetent and replication-competent adenoviral vectors. Our findings suggest that cell death caused by replication-competent adenoviral vectors is required to induce a significant anti-tumor immune response and survival benefits in ... Author: Julius W. Kim, Jason Miska, Jacob S. Young, Aida Rashidi, J. Robert Kane, Wojciech K. Panek, Deepak ... Publish Year: 2017 DOI: 10.1016/j.omto.2017.05.001 Publication: Mol Ther Oncolytics. 2017 Jun 16; 5: 97-104.

Author: Julius W. Kim, Jason Miska, Jacob S. Young, Aida Rashidi, J. Robert Kane, Wojciech K. Panek, Deepak ...
Publish Year: 2017
DOI: 10.1016/j.omto.2017.05.001
Publication: Mol Ther Oncolytics. 2017 Jun 16; 5: 97-104.

DA: 6 PA: 77 MOZ Rank: 6

Meeting FDA Guidance recommendations for replication-competent virus
nih.gov

https://pubmed.ncbi.nlm.nih.gov/36588821/

WEBDec 2, 2022 · Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testing. Mol Ther Methods Clin Dev. 2022 Dec 2:28:28-39. doi: 10.1016/j.omtm.2022.11.009. eCollection 2023 Mar 9.

DA: 6 PA: 79 MOZ Rank: 33

Defective viral genomes are key drivers of the virus–host interaction
nature.com

https://www.nature.com/articles/s41564-019-0465-y

WEBJun 3, 2019 · Main. Viruses are remarkably resilient microorganisms able to adapt and survive in the complex host physiological and immune environment. Accumulating evidence demonstrates that viruses can...

DA: 72 PA: 47 MOZ Rank: 11

Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging
nih.gov

https://pubmed.ncbi.nlm.nih.gov/26176173/

WEBReplication-competent (oncolytic) viruses (OV) as cancer immunotherapeutics have gained an increasing level of attention over the last few years while the clinical evidence of virus-mediated antitumor immune responses is still anecdotal.

DA: 9 PA: 38 MOZ Rank: 61

Organ-specific genome diversity of replication-competent SARS ... - Nature
nature.com

https://www.nature.com/articles/s41467-021-26884-7

WEBNov 16, 2021 · We report a detailed virological analysis of thirteen postmortem coronavirus disease 2019 (COVID-19) cases that provides proof of viremia and presence of replication-competent SARS-CoV-2 in...

DA: 72 PA: 48 MOZ Rank: 23